-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $92

Benzinga·04/06/2026 17:12:35
Listen to the news
Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $94 to $92.